title: Differential cerebellar GABAA receptor expression in mice with mutations in CaV2.1 (P/Q-type) calcium channels.
abstract: Ataxia is the predominant clinical manifestation of cerebellar dysfunction. Mutations in the human CACNA1A gene, encoding the pore-forming α1 subunit of CaV2.1 (P/Q-type) calcium channels, underlie several neurological disorders, including Episodic Ataxia type 2 and Familial Hemiplegic Migraine type 1 (FHM1). Several mouse mutants exist that harbor mutations in the orthologous Cacna1a gene. The spontaneous Cacna1a mutants Rolling Nagoya (tg(rol)), Tottering (tg) and Leaner (tg(ln)) mice exhibit behavioral motor phenotypes, including ataxia. Transgenic knock-in (KI) mouse strains with the human FHM1 R192Q and S218L missense mutations have been generated. R192Q KI mice are non-ataxic, whereas S218L KI mice display a complex behavioral phenotype that includes cerebellar ataxia. Given the dependence of γ-aminobutyric acid type A (GABAA) receptor subunit functioning on localized calcium currents, and the functional link between GABAergic inhibition and ataxia, we hypothesized that cerebellar GABAA receptor expression is differentially affected in Cacna1a mutants and contributes to the ataxic phenotype. Herein we quantified functional GABAA receptors and pharmacologically dissociated cerebellar GABAA receptors in several Cacna1a mutants. We did not identify differences in the expression of GABAA receptor subunits or in the number of functional GABAA receptors in the non-ataxic R192Q KI strain. In contrast, tg(rol) mice had a ∼15% decrease in the number of functional GABAA receptors, whereas S218L KI mice showed a ∼29% increase. Our data suggest that differential changes in cerebellar GABAA receptor expression profile may contribute to the neurological phenotype of cerebellar ataxia and that targeting GABAA receptors might represent a feasible complementary strategy to treat cerebellar ataxia.
authors.affiliation: Michael Smith Laboratories and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada; NeuroSearch A/S, Pederstrupvej 93, 2750 Ballerup, Denmark; Vision Research Center, Department of Ophthalmology, University of Missouri - Kansas City, School of Medicine, 2411 Holmes Street, Kansas City, MO 64108, USA; K&P Scientific LLC, 8570 N Hickory Street Suite 412, Kansas City, MO 64155, USA. Electronic address: skaja@luc.edu.
authors.forename: S
authors.initials: S
authors.lastname: Kaja
authors.affiliation: Vision Research Center, Department of Ophthalmology, University of Missouri - Kansas City, School of Medicine, 2411 Holmes Street, Kansas City, MO 64108, USA; K&P Scientific LLC, 8570 N Hickory Street Suite 412, Kansas City, MO 64155, USA.
authors.forename: A J
authors.initials: AJ
authors.lastname: Payne
authors.affiliation: NeuroSearch A/S, Pederstrupvej 93, 2750 Ballerup, Denmark.
authors.forename: E Ø
authors.initials: EØ
authors.lastname: Nielsen
authors.affiliation: School of Biological Sciences, Durham University, South Road, Science Laboratories, Durham DH1 3LE, United Kingdom.
authors.forename: C L
authors.initials: CL
authors.lastname: Thompson
authors.affiliation: Departments of Human Genetics & Neurology, Leiden University Medical Centre, Einthovenweg 20, PO Box 9600, 2300 RC Leiden, The Netherlands.
authors.forename: A M J M
authors.initials: AM
authors.lastname: van den Maagdenberg
authors.affiliation: Vision Research Center, Department of Ophthalmology, University of Missouri - Kansas City, School of Medicine, 2411 Holmes Street, Kansas City, MO 64108, USA; Department of Basic Medical Science, University of Missouri - Kansas City, School of Medicine, 2411 Holmes Street, Kansas City, MO 64108, USA.
authors.forename: P
authors.initials: P
authors.lastname: Koulen
authors.affiliation: Michael Smith Laboratories and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada.
authors.forename: T P
authors.initials: TP
authors.lastname: Snutch
mesh_terms: D000818:Animals; D001259:Ataxia / Q000378:metabolism / Q000473:pathology; D020864:Calcium Channels, N-Type / Q000235:genetics / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism* / Q000473:pathology*; D055879:Gene Knock-In Techniques; D006801:Humans; D008822:Mice, Transgenic; D009154:Mutation; D009474:Neurons / Q000378:metabolism* / Q000473:pathology*; D010641:Phenotype; D011963:Receptors, GABA-A / Q000378:metabolism
chemical_list: D020864:Calcium Channels, N-Type; D011963:Receptors, GABA-A
keywords: Cacna1a; Familial Hemiplegic Migraine; cerebellar ataxia; gamma aminobutyric acid receptor type A; pharmacology